Investor Relations

Trading On:

CSE: VPH  |  OTCQB: VPHIF  |  FSE: VP2

Valeo Pharma (CSE:VPH) is a Canadian pharmaceutical company focused on four therapeutic areas: Respiratory, Neurology, Oncology and Specialty Products. Within these areas Valeo now has 8 marketed brands and 4 additional products contributing to significant growth for the coming year.

Investor Relation Contact

Frederic Dumais
Director Communications & Investor Relations
dumais@valeopharma.com

Head Office

16667, Hymus Boul.
Kirkland, Qc
H9H 4R9

Analysts

Chelsea Stellick
Industrial Alliance
1 (403)705-4982

Scott McAuley
Paradigm Capital
1 (416) 361-9080

Andre Uddin
Research Capital Corporation
1 (416) 860-8675